Adherence to assigned dosing regimen in chronic Hep C genotype 1 patients

July's issue of Alimentary Pharmacology & Therapeutics investigates adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.

Adherence to therapeutic regimens affects the efficacy of peginterferon alfa and ribavirin therap